Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of medicine and application thereof for preventing or treating fatty liver

A technology for fatty liver and simple fatty liver, applied in the field of medicine and biology, can solve problems such as strong side effects and difficulty in controlling the efficacy of drugs, and achieve the effect of repairing oxidative damage

Active Publication Date: 2020-02-18
DALIAN UNIV OF TECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The object of the present invention is to provide a kind of medicine of prevention and treatment fatty liver, especially non-alcoholic fatty liver, to solve the defects such as difficulty in control of the medicine in the prior art, weak drug effect, strong side effect, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of medicine and application thereof for preventing or treating fatty liver
  • A kind of medicine and application thereof for preventing or treating fatty liver
  • A kind of medicine and application thereof for preventing or treating fatty liver

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1: Effect evaluation of oreoside A on prevention and treatment of non-alcoholic fatty liver

[0028]Take 18-22g Kunming mice and feed them with the high-fat and high-sugar foods shown in Table 1 continuously for 5 weeks, select the mice with the top 50% of body weight as model mice, and divide the model mice and normal mice into males and females Randomly divided into groups A-D, 4 groups in total, 10 mice in each group, half male and half male, respectively labeled, wherein group A is normal mice, and group B-D are model mice. Group A was fed with common feed and gavaged 0.5% sodium carboxymethyl cellulose solution once a day; group B was fed with high-fat feed and gavaged 0.5% sodium carboxymethyl cellulose solution once a day; group C was fed with high-fat feed and gavaged every day One time 200mg / kg of oreoside A (dissolved in 0.5% sodium carboxymethyl cellulose solution); D group feeding high-fat feed every day once 4mg / kg Rosiglitazone (dissolved in 0.5% c...

Embodiment 2

[0037] Example 2: Effect evaluation of different doses of oreoside A on prevention and treatment of non-alcoholic fatty liver

[0038] Take 18-22g Kunming mice and feed them with the high-fat and high-sugar foods shown in Table 1 continuously for 5 weeks, select the mice with the top 50% of body weight as model mice, and divide the model mice and normal mice into males and females Randomly grouped into groups A-E, 4 groups in total, 10 mice in each group, half male and half male, respectively labeled, wherein group A is normal mice, and group B-D are model mice. Group A was fed with common feed and gavaged 0.5% sodium carboxymethyl cellulose solution once a day; group B was fed with high-fat feed and gavaged 0.5% sodium carboxymethyl cellulose solution once a day; group C was fed with high-fat feed and gavaged every day The oreoside A of 50mg / kg once (dissolved in 0.5% sodium carboxymethyl cellulose solution); D group feeds the high-fat feed and gavages once a day the oreoside...

Embodiment 3

[0042] Example 3: Comparison of the effects of different flavonoid components on non-alcoholic fatty liver

[0043] Take 18-22g Kunming mice and feed them with the high-fat and high-sugar foods shown in Table 1 continuously for 5 weeks, select the mice with the top 50% of body weight as model mice, and divide the model mice and normal mice into males and females Randomly divided into groups A-H, 8 groups in total, 10 mice in each group, half male and half male, respectively labeled, of which group A is normal mice, B is model mice, and groups C-H use model mice to administer various flavonoid ingredients , flavonoids are all soluble in 0.5% sodium carboxymethyl cellulose solution. Group A was fed with common feed and gavaged 0.5% sodium carboxymethyl cellulose solution once a day; group B was fed with high-fat feed and gavaged 0.5% sodium carboxymethyl cellulose solution once a day; group C was fed with high-fat feed and gavaged every day Oreoside A at 800mg / kg once; Group D ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for preventing or treating fatty liver and application thereof. The medicine can effectively prevent or treat pimelosis of nonalcoholic fatty liver, repair oxidative injury of liver tissue and maintain the functions of the liver. The medicine contains an effective dose of oroxin A and optionally contains a pharmaceutically acceptable carrier and / or excipient, and the dosage forms of the medicine include tablets, orally disintegrating tablets, sustained release tablets, granules, capsules, freeze-dried powder injection, pills, suspension, syrup, emulsion or injection.

Description

technical field [0001] The invention relates to a medicament for preventing or treating fatty liver and its application, which can effectively prevent or treat fatty liver caused by non-alcoholic fatty liver, repair oxidative damage of liver tissue and maintain liver function; it belongs to the field of medicine and biology. Background technique [0002] With the development of our country's social economy and the improvement of people's living standards, alcoholism, unhealthy eating habits and a lack of exercise lifestyle are harmful to health, especially the liver, which makes fatty liver disease (also known as fatty liver) the onset The rate of liver disease also increased significantly, and it has become the second largest high-incidence liver disease after viral hepatitis, seriously threatening human health. Fatty liver can be clinically divided into alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD) according to its etiology. The main p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P1/16
CPCA61K31/7048
Inventor 董悦生孙文龙张博崴李夏修志龙
Owner DALIAN UNIV OF TECH